Potential Role of Hyperglycemia in Fetoplacental Endothelial Dysfunction in Gestational Diabetes Mellitus
Author(s) -
Jian Zhou,
Xiaotian Ni,
Xiaojie Huang,
Julei Yao,
Qizhi He,
Kai Wang,
Tao Duan
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000447836
Subject(s) - angiogenesis , vascular endothelial growth factor , endocrinology , medicine , fibroblast growth factor , human umbilical vein endothelial cell , umbilical vein , placental growth factor , endothelial stem cell , matrigel , placenta , mapk/erk pathway , biology , cell growth , signal transduction , microbiology and biotechnology , fetus , biochemistry , receptor , in vitro , pregnancy , genetics , vegf receptors
Gestational diabetes mellitus (GDM) is associated with structural and functional alterations in various tissues including endothelial dysfunction. The aim of this study was to explore the effects of hyperglycemia on fibroblast growth factor 2 (FGF2)- and vascular endothelial growth factor (VEGF)-stimulated placental angiogenesis and the underlying molecular signaling mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom